Sibenaller ZA - Search Results

1

Genetic characterization of commonly used glioma cell lines in the rat animal model system.

Sibenaller ZA, Etame AB, Ali MM, Barua M, Braun TA, Casavant TL, Ryken TC. Sibenaller ZA, et al. Neurosurg Focus. 2005 Oct 15;19(4):E1. doi: 10.3171/foc.2005.19.4.2. Neurosurg Focus. 2005. PMID: 16241103

2

Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001.

Deorah S, Lynch CF, Sibenaller ZA, Ryken TC. Deorah S, et al. Among authors: sibenaller za. Neurosurg Focus. 2006 Apr 15;20(4):E1. doi: 10.3171/foc.2006.20.4.E1. Neurosurg Focus. 2006. PMID: 16709014

3

Genome-wide analysis of epigenetic silencing identifies BEX1 and BEX2 as candidate tumor suppressor genes in malignant glioma.

Foltz G, Ryu GY, Yoon JG, Nelson T, Fahey J, Frakes A, Lee H, Field L, Zander K, Sibenaller Z, Ryken TC, Vibhakar R, Hood L, Madan A. Foltz G, et al. Cancer Res. 2006 Jul 1;66(13):6665-74. doi: 10.1158/0008-5472.CAN-05-4453. Cancer Res. 2006. PMID: 16818640

4

Tumor derived mutations of protein tyrosine phosphatase receptor type k affect its function and alter sensitivity to chemotherapeutics in glioma.

Agarwal S, Al-Keilani MS, Alqudah MA, Sibenaller ZA, Ryken TC, Assem M. Agarwal S, et al. Among authors: sibenaller za. PLoS One. 2013 May 16;8(5):e62852. doi: 10.1371/journal.pone.0062852. Print 2013. PLoS One. 2013. PMID: 23696788 Free PMC article.

5

NOTCH3 is a prognostic factor that promotes glioma cell proliferation, migration and invasion via activation of CCND1 and EGFR.

Alqudah MA, Agarwal S, Al-Keilani MS, Sibenaller ZA, Ryken TC, Assem M. Alqudah MA, et al. Among authors: sibenaller za. PLoS One. 2013 Oct 15;8(10):e77299. doi: 10.1371/journal.pone.0077299. eCollection 2013. PLoS One. 2013. PMID: 24143218 Free PMC article.

6

Enhancing diagnosis, prognosis, and therapeutic outcome prediction of gliomas using genomics.

Assem M, Sibenaller Z, Agarwal S, Al-Keilani MS, Alqudah MA, Ryken TC. Assem M, et al. OMICS. 2012 Mar;16(3):113-22. doi: 10.1089/omi.2011.0031. OMICS. 2012. PMID: 22401657 Free PMC article.

7

Integrated genomic and epigenomic analysis of breast cancer brain metastasis.

Salhia B, Kiefer J, Ross JT, Metapally R, Martinez RA, Johnson KN, DiPerna DM, Paquette KM, Jung S, Nasser S, Wallstrom G, Tembe W, Baker A, Carpten J, Resau J, Ryken T, Sibenaller Z, Petricoin EF, Liotta LA, Ramanathan RK, Berens ME, Tran NL. Salhia B, et al. PLoS One. 2014 Jan 29;9(1):e85448. doi: 10.1371/journal.pone.0085448. eCollection 2014. PLoS One. 2014. PMID: 24489661 Free PMC article.

8

DNA methyltransferase-mediated transcriptional silencing in malignant glioma: a combined whole-genome microarray and promoter array analysis.

Foltz G, Yoon JG, Lee H, Ryken TC, Sibenaller Z, Ehrich M, Hood L, Madan A. Foltz G, et al. Oncogene. 2009 Jul 23;28(29):2667-77. doi: 10.1038/onc.2009.122. Epub 2009 May 25. Oncogene. 2009. PMID: 19465937

9

Sample type bias in the analysis of cancer genomes.

Solomon DA, Kim JS, Ressom HW, Sibenaller Z, Ryken T, Jean W, Bigner D, Yan H, Waldman T. Solomon DA, et al. Cancer Res. 2009 Jul 15;69(14):5630-3. doi: 10.1158/0008-5472.CAN-09-1055. Epub 2009 Jun 30. Cancer Res. 2009. PMID: 19567670 Free PMC article.

10

MicroRNA-328 is associated with (non-small) cell lung cancer (NSCLC) brain metastasis and mediates NSCLC migration.

Arora S, Ranade AR, Tran NL, Nasser S, Sridhar S, Korn RL, Ross JT, Dhruv H, Foss KM, Sibenaller Z, Ryken T, Gotway MB, Kim S, Weiss GJ. Arora S, et al. Int J Cancer. 2011 Dec 1;129(11):2621-31. doi: 10.1002/ijc.25939. Epub 2011 Mar 29. Int J Cancer. 2011. PMID: 21448905 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters